Objective: To compare clinical characteristics and examine in-hospital length of stay (LOS) differences for COVID-19 patients who received remdesivir, by race or ethnicity.
Design: Retrospective descriptive analysis comparing cumulative LOS as a proxy of recovery time.
Setting: A large academic medical center serving a minoritized community in Northern Manhattan, New York City.